Ablynx's P2P Acquisition

Ablynx raised a round of funding on June 19, 2018. Investors include Sanofi.

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies to treat a range of serious human diseases. Nanobodies are a novel class of antibody-derived therapeutic pr…

Articles about Ablynx's P2P Acquisition: